Director, Value Outcomes Liaison (VOL)
Core
Director responsible for interfacing with US population-based decision makers (PBDMs) including payers, health systems, and policy makers to educate them on the clinical, economic, and humanistic impact of ivonescimab to inform formulary access and pathway decisions.
Role type
Senior IC Director, Value Outcomes Liaison (Market Access/HEOR)
Builds
Formulary access and treatment pathway inclusion for ivonescimab in oncology
Domain
Biopharmaceuticals / Oncology / Health Economics and Outcomes Research (HEOR)
Required skills
Health Economics and Outcomes Research (HEOR), Market Access strategy, Payer engagement, Clinical pathway management, Real-world evidence (RWE) analysis, Data analysis, Stakeholder management, Scientific communication
Preferred skills
Oncology domain expertise (NSCLC), Health Services Research background
Technologies
Economic models, Outcomes tools, RWE databases
Responsibilities
Cultivate and manage relationships with PBDMs including payers, PBM, GPOs, and IDNs; Collaborate with internal HEOR and market access teams to execute scientific engagement strategies; Serve as a conduit for providing clinical and healthcare economic information to formulary decision-makers; Capture and communicate stakeholder insights and evidence gaps; Understand medical affairs priorities to contribute to content strategy; Work with stakeholders to ensure inclusion of ivonescimab in clinical/payer pathways and treatment order sets; Utilize and present clinical, humanistic, and economic evidence to the payer audience.
Seniority
Director, strategic leadership with hands-on execution